Download Medical Notes on 2020 US and global life sciences outlook

2020 US and global life sciences outlook Medical Notes

About This Presentation

Description:Intelligent drug discovery and development, gene therapies, telemedicine, consumer wearables, and more—what are some of the factors transforming the life sciences sector? How biopharma and medtech organizations can generate new value in 2020, while confronting different challenges? What are the metrics that matter? The report will tell you. This Deloitte report contains the US perspective on life sciences trends. This 2020 global life sciences outlook takes an in-depth look into why life sciences companies should consider creating a holistic patient experience.

Tags:pharma, pharmaceutical, pharmaceutical industry, drugs, medicine, life sciences, outlook, drug discovery, drug development, gene therapies, telemedicine, consumer wearables

Published on: Jul 02, 2020 | Views : 1610 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

Taming big Pharma

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 - Booklet 4.2

Biopharmaceuticals in Perspective

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 - Booklet 5

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 4

EvaluatePharma Orphan Drug Report 2020

COVID-19: Super-charging Drug Development in the Race for a Cure

Indian API (Active Pharmaceutical Ingredient) Industry - Reaching The Full Potential

Diabetes Costs and Affordability in the United States

Evaluate Vantage Report on impact of COVID-19 Biopharma and Medtech

HEALTH A TO Z